Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Professor Psaila, who has received the 2026 Janet Rowley Award from the International Society for Experimental Hematology, in recognition of her outstanding contributions in the field of experimental haematology.

Bethan Psaila, Professor of Haematology in the MRC Molecular Haematology Unit and member of the OxCODE Operational Group, was presented with the 2026 Janet Rowley Award from the International Society for Experimental Hematology (ISEH) at the ISEH 55th Annual Scientific Meeting in Frankfurt, Germany on 30th August 2026. As part of the award, Bethan delivered the Janet Rowley Award Lecture, Exploring the MEGAverse – megakaryocytes, platelets and myeloproliferative neoplasms.

Established in 2020, the award recognises early-career scientists who have made outstanding scientific contributions to the field of experimental haematology. It is named in honour of Professor Janet Rowley, a pioneering human geneticist whose discoveries established the importance of chromosomal changes in blood cancers.

The award recognises the breadth of Bethan’s research, from fundamental studies of megakaryocyte and platelet biology and the bone marrow microenvironment to translational research in myeloproliferative neoplasms (MPNs), a group of chronic blood cancers. Her work seeks to uncover the mechanisms that drive these diseases and identify potential new therapeutic and preventative approaches.

Similar stories

Fallopian tube immune cells could offer new route to prevent and treat ovarian cancer

Research led by Professor Ahmed Ahmed and Dr Nancy Zaarour has identified a population of immune cells in the fallopian tubes that can recognise ovarian cancer cells, raising the possibility of harnessing the body's early immune defences to develop new ways to prevent or treat the disease.

Oxford Sparks video on preventive cancer vaccines

In this new video from Oxford Sparks, Professor David Church describes his research to develop vaccines to prevent cancer.

Similar stories

Fallopian tube immune cells could offer new route to prevent and treat ovarian cancer

Research led by Professor Ahmed Ahmed and Dr Nancy Zaarour has identified a population of immune cells in the fallopian tubes that can recognise ovarian cancer cells, raising the possibility of harnessing the body's early immune defences to develop new ways to prevent or treat the disease.

Oxford Sparks video on preventive cancer vaccines

In this new video from Oxford Sparks, Professor David Church describes his research to develop vaccines to prevent cancer.